ABVX Abivax SA American Depositary Shares : Bullish and Bearish Analyst Opinions
Sentiment & Price
▼
Sentiment Gauge
1
Bull
0
Bear
0
Watch
Bull 100%
Bear 0%
Price & Sentiment
Loading chart...
Recent News
Top Views ▼
No recent news for ABVX
No theses available
Feed
12:21
Apr 13
Apr 13
Maintain long exposure to ABVX despite competitor data, as SYRE's Phase 2a study is eight years behind and methodologically inferior due to its open-label design.
HIGH
23:07
Mar 31
Mar 31
The user expresses relief or resilience regarding their positions in ABVX and SLNO.
17:20
Mar 27
Mar 27
The trader is aggressively selling puts on ABVX and SLNO, indicating a bullish outlook.
01:07
Mar 25
Mar 25
The author defends ABVX against negative analyst commentary regarding their phase 2 clinical trial data.
16:09
Mar 24
Mar 24
The author views the recent sell-off as a logical reaction to known trial and earnings data while emphasizing the need for maintenance data.
21:28
Mar 23
Mar 23
The author maintains a long position in ABVX following an earnings update regarding the timeline for upcoming maintenance data.
20:09
Mar 23
Mar 23
ABVX stock sentiment improves after the company hired a high-profile executive to lead commercial efforts.
21:02
Mar 20
Mar 20
ABVX management signals positive developments including a new CCO hire and optimistic maintenance data.
19:23
Mar 15
Mar 15
Jefferies initiates coverage on ABVX with a $160 price target, citing a de-risked path to approval for their UC drug.
18:29
Mar 15
Mar 15
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
14:24
Mar 12
Mar 12
Abivax denies reports of exclusive information access granted to AstraZeneca regarding a potential offer.
About ABVX Analyst Coverage
Buzzberg tracks ABVX (Abivax SA American Depositary Shares) across 2 sources. 10 bullish vs 1 bearish calls from 2 analysts. Sentiment: predominantly bullish (69%). 13 total trade ideas tracked.